Support Skin Wellness from Within
Vigiis® 101 for Pets is a clinically supported probiotic, now specially formulated for pets. Discovered by National Taiwan University, this powerful strain survives 95% through digestive stress and is supported by 40 scientific studies. It is designed to support healthy skin and reduce symptoms of itching, redness, and sensitivity caused by atopic dermatitis in dogs and cats—helping your furry companions feel comfortable in their skin again.
- Drug-resistant gene-free and genetically stable
- Survives gastrointestinal conditions with strong adherence capability
- Backed by multiple clinical trials and scientific evidence for digestive and skin health
Gut-Skin Axis
The emerging concept of the gut-skin axis highlights the bidirectional relationship between the gut microbiome and skin health. Atopic dermatitis (AD), a chronic inflammatory skin disorder, significantly impacts quality of life. Increasing evidence suggests that modulating the gut microbiota with probiotics can help maintain skin health—further supporting the crucial role of the gut-skin axis.
Maintaining Healthy Skin from the Inside Out
By balancing the gut flora, Vigiis® 101 for Pets not only enhances overall immunity for atopic dermatitis, it effectively promote the generation of regulatory T cells (Treg), as well as Th1/Th2 balance, which play a crucial role in regulating immune responses. This helps reduce excessive immune reactions and inflammation, thereby maintaining healthy skin from the inside out.
After 8 weeks of daily supplementation with Vigiis® 101-LAB, one individual reported noticeable changes around the ear. This aligns with growing scientific insights into the role of the gut-skin axis—highlighting how a healthy gut microbiome may support skin health from the inside out.*
John, SunWay President
Applications
Our comprehensive portfolio of global patents underscores our commitment to innovation and ensures that our clients’ investments will significantly influence the market.
Market Insight
1. In-house studies
The communication is intended for business-to-business information and not for the final consumer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.